TrialPanorama/TrialPanorama-database huggingface dataset:
Study 36881395 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34023009 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 34023009 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 34023009 — Predictive Biomarker (PRD): JAK3 mRNA
Genes: JAK3
Study 35665810 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 35665810 — Predictive Biomarker (PRD): GAD2 mRNA
Genes: GAD2; GAD65
Study 32506738 — Surrogate Endpoint (SUR): Blood pressure
Study 34802065 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34802065 — Surrogate Endpoint (SUR): Blood pressure
Study 34802065 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 36574401 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 36273926 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 36273926 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 36273926 — Predictive Biomarker (PRD): RAD51C mRNA
Genes: RAD51C; RAD51L2
Study 36273926 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 35947348 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32694216 — Surrogate Endpoint (SUR): Serum creatinine
Study 34844191 — Predictive Biomarker (PRD): SCARB2 mRNA
Genes: SCARB2; CD36L2; LIMP2; LIMPII
Study 35916880 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35970518 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33734138 — Surrogate Endpoint (SUR): Blood pressure
Study 35684041 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study 35657581 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 32758179 — Predictive Biomarker (PRD): SPAAR mRNA
Genes: SPAAR; LINC00961; SPAR
Study 33176409 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 33072067 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33072067 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 36082969 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 36082969 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 35440501 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 35440501 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34538401 — Safety Biomarker (SAF): XRCC1
Genes: RCC
Study 34283183 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32650223 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34474735 — Surrogate Endpoint (SUR): Blood pressure
Study 36346543 — Surrogate Endpoint (SUR): Blood pressure
Study 33576770 — Surrogate Endpoint (SUR): Blood pressure
Study 35351194 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 32192742 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32705504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32705504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32705504 — Surrogate Endpoint (SUR): Blood pressure
Study 32086341 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32086341 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32086341 — Safety Biomarker (SAF): Derived neutrophil to lymphocyte
Study 32086341 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 35728557 — Surrogate Endpoint (SUR): Bacterial count
Study 35406052 — Surrogate Endpoint (SUR): Blood pressure
Study 35338131 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 33164941 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 34076644 — Predictive Biomarker (PRD): MTLN mRNA
Genes: MTLN; LEMP; LINC00116; MOXI; MPM; NCRNA00116; SMIM37
Study 33822986 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 34196980 — Surrogate Endpoint (SUR): Blood pressure
Study 32890282 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32890282 — Surrogate Endpoint (SUR): Blood pressure
Study 32890282 — Surrogate Endpoint (SUR): Serum creatinine
Study 35410433 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34233378 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32576228 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32576228 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32576228 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 33249759 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study 33249759 — Predictive Biomarker (PRD): SLC10A3 mRNA
Genes: SLC10A3; DXS253E; P3
Study 34083233 — Predictive Biomarker (PRD): WIF1 mRNA
Genes: WIF1; UNQ191/PRO217
Study 34083233 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 34083233 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 32530412 — Surrogate Endpoint (SUR): Serum creatinine
Study 35551757 — Predictive Biomarker (PRD): CD247 mRNA
Genes: CD247; CD3Z; T3Z; TCRZ
Study 33496535 — Surrogate Endpoint (SUR): Blood pressure
Study 33555548 — Surrogate Endpoint (SUR): Serum creatinine
Study 32149427 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study 32692763 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study 32692763 — Safety Biomarker (SAF): miR-214
Genes: MIR214
Study 33642833 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 36126736 — Surrogate Endpoint (SUR): Blood pressure
Study 33714746 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32955174 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 32955174 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 33504345 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 35123461 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 33059754 — Monitoring Biomarker (MOI): Macrophage inflammatory protein 1-alpha
Genes: CCL3; G0S19-1; MIP1A; SCYA3
Study 33059754 — Monitoring Biomarker (MOI): C-C motif chemokine 4
Genes: CCL4; LAG1; MIP1B; SCYA4
Study 33059754 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 33059754 — Predictive Biomarker (PRD): Small-inducible cytokine A11
Genes: CCL11; SCYA11
Study 33861440 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33861440 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36153442 — Surrogate Endpoint (SUR): Blood pressure
Study 36153442 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33992687 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35426602 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study 32561489 — Surrogate Endpoint (SUR): Blood pressure
Study 35809896 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33846728 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study 33502809 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 35403395 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 33788485 — Predictive Biomarker (PRD): SLBP mRNA
Genes: SLBP; HBP
Study 35350436 — Predictive Biomarker (PRD): GAL3ST1 mRNA
Genes: GAL3ST1; CST
Study 34287673 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 34287673 — Predictive Biomarker (PRD): GYPC mRNA
Genes: GYPC; GLPC; GPC
Study 34590746 — Surrogate Endpoint (SUR): Serum creatinine
Study 35430521 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 33863352 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32963266 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 33038502 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 34881670 — Surrogate Endpoint (SUR): Blood pressure
Study 32083990 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34476095 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study 33564963 — Predictive Biomarker (PRD): PPARGC1A mRNA
Genes: PPARGC1A; LEM6; PGC1; PGC1A; PPARGC1
Study 33564963 — Predictive Biomarker (PRD): PDK4 mRNA
Genes: PDK4; PDHK4
Study 34175554 — Surrogate Endpoint (SUR): Blood pressure
Study 34175554 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32363743 — Surrogate Endpoint (SUR): Serum uric acid
Study 32363743 — Surrogate Endpoint (SUR): Blood pressure
Study 34473544 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 32937045 — Surrogate Endpoint (SUR): Complete renal response
Study 33040782 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33040782 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 33040782 — Safety Biomarker (SAF): BDNF
Study 34428740 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32723754 — Surrogate Endpoint (SUR): Blood pressure
Study 34588952 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study 34802879 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34802879 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34802879 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32049191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32563539 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 35395383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33023185 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 32967495 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32967495 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32967495 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 32583931 — Predictive Biomarker (PRD): LTB4R mRNA
Genes: LTB4R; BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7
Study 32189061 — Surrogate Endpoint (SUR): Blood pressure
Study 2010124724 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 35016998 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32272517 — Safety Biomarker (SAF): Hyaluronic acid
Study 35177255 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 35177255 — Predictive Biomarker (PRD): IRF7 mRNA
Genes: IRF7
Study 35177255 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35177255 — Monitoring Biomarker (MOI): Macrophage inflammatory protein 1-alpha
Genes: CCL3; G0S19-1; MIP1A; SCYA3
Study 35011603 — Surrogate Endpoint (SUR): Blood pressure
Study 36401084 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35382631 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study 32960007 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32960007 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 33642051 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33642051 — Surrogate Endpoint (SUR): Blood pressure
Study 32516744 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33731516 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33731516 — Surrogate Endpoint (SUR): Blood pressure
Study 32484534 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34936269 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34936269 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 34936269 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 34936269 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32334845 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 35157527 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 36197520 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 32131476 — Predictive Biomarker (PRD): SELENOP mRNA
Genes: SELENOP; SELP; SEPP1
Study 35641257 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 35064870 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study 35064870 — Predictive Biomarker (PRD): FOXP3 mRNA
Genes: FOXP3; IPEX; JM2
Study 35064870 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 35064870 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 33909355 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32885455 — Safety Biomarker (SAF): Reactive oxygen species
Study 32885455 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 34019819 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34019819 — Predictive Biomarker (PRD): Hormone receptor
Study 32276003 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 33625693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35696023 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33429063 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 33313728 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 34255420 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 34082300 — Surrogate Endpoint (SUR): Blood pressure
Study 34570156 — Predictive Biomarker (PRD); Safety Biomarker (SAF): FGG mRNA
Genes: FGG; PRO2061
Study 34118282 — Predictive Biomarker (PRD): EMP1 mRNA
Genes: EMP1; B4B; TMP
Study 35165727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35165727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33472259 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 32422956 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32422956 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36067740 — Surrogate Endpoint (SUR): Blood pressure
Study 33339768 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 33332232 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33332232 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33332232 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 33150590 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33150590 — Predictive Biomarker (PRD): CCL22 mRNA
Genes: CCL22; MDC; SCYA22; A-152E5.1
Study 33103229 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 36259713 — Surrogate Endpoint (SUR): Blood pressure
Study 34187832 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34585780 — Surrogate Endpoint (SUR): Bone mineral density
Study 32070681 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32507842 — Surrogate Endpoint (SUR): Blood pressure
Study 36171728 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32248629 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 35589454 — Surrogate Endpoint (SUR): Blood pressure
Study 34061467 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CD180 mRNA
Genes: CD180; LY64; RP105
Study 34061467 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study 34061467 — Predictive Biomarker (PRD): CD200 mRNA
Genes: CD200; MOX1; MOX2; My033
Study 33407337 — Safety Biomarker (SAF): Hyaluronic acid
Study 34685778 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 34685778 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study 34685778 — Predictive Biomarker (PRD): TNFRSF10B mRNA
Genes: TNFRSF10B; DR5; KILLER; TRAILR2; TRICK2; ZTNFR9; UNQ160/PRO186
Study 34685778 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 34685778 — Predictive Biomarker (PRD): Interleukin 4 receptor alpha
Genes: IL4R; IL4RA; 582J2.1
Study 34685778 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study 35837707 — Predictive Biomarker (PRD): H3-3A mRNA
Genes: H3-3A; H3.3A; H3F3; H3F3A; PP781;; H3-3B; H3.3B; H3F3B
Study 33040465 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 33040465 — Surrogate Endpoint (SUR): Bone mineral density
Study 35950283 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 34021020 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34021020 — Predictive Biomarker (PRD): GAD2 mRNA
Genes: GAD2; GAD65
Study 32709912 — Safety Biomarker (SAF): BDNF
Study 32709912 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32709912 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34876454 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34547529 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33235104 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 33235104 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34534493 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 34534493 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 32448136 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34294923 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 32276609 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34304248 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 36366373 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35821033 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35821033 — Surrogate Endpoint (SUR): Blood pressure
Study 33232470 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 35397159 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 33980234 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 36165726 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 33369625 — Predictive Biomarker (PRD): MAP3K10 mRNA
Genes: MAP3K10; MLK2; MST
Study 34263919 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 32991788 — Predictive Biomarker (PRD): ADRA2A mRNA
Genes: ADRA2A; ADRA2R; ADRAR
Study 32991788 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 32991788 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study 32991788 — Predictive Biomarker (PRD): HTR2C mRNA
Genes: HTR2C; HTR1C
Study 32991788 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 32991788 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 32991788 — Surrogate Endpoint (SUR): Blood pressure
Study 35148973 — Safety Biomarker (SAF): OPRM1
Genes: MOR1; MOP
Study 32960053 — Predictive Biomarker (PRD): Hormone receptor
Study 35002538 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 34159691 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 34755130 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 32568096 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 32568096 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34319247 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34319247 — Surrogate Endpoint (SUR): Blood pressure
Study 35821047 — Surrogate Endpoint (SUR): Bone mineral density
Study 32698957 — Predictive Biomarker (PRD): Hormone receptor
Study 33397017 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33397017 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33397017 — Surrogate Endpoint (SUR): Blood pressure
Study 32769526 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 36186488 — Surrogate Endpoint (SUR): Blood pressure
Study 32469406 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35088725 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 34644368 — Surrogate Endpoint (SUR): Serum creatinine
Study 32543161 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study 35232482 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 34921756 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32024551 — Surrogate Endpoint (SUR): Blood pressure
Study 34193056 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34193056 — Safety Biomarker (SAF): Interleukin 1
Study 34193056 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32108022 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 36013137 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 36013137 — Safety Biomarker (SAF): BDNF
Study 33599431 — Predictive Biomarker (PRD): GARS1 mRNA
Genes: GARS1; GARS
Study 34866304 — Surrogate Endpoint (SUR): Bone mineral density